Dark

Check out our Level2View

GCAN
GREATER CANNABIS CO
stock OTC

EOD

Aug 10, 2026

0.2800USD-25.867%(-0.0977)2,038

Pre-market

0.00USD-100.000%(-0.28)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Dec 16, 2021

09:35AM EST The 6th Installment in the Award-winning Series by Dr. Sanjay Gupta will Air on Sunday, December 19th at 9pm ET GlobeNewswire Inc

Dec 6, 2021

04:39PM EST Cannabis Movers & Shakers: Coda Signature, Greater Cannabis Co., BioHarvest Sciences, Compass Pathways Benzinga

Dec 2, 2021

08:52AM EST Dr. Aran will be focused on furthering development of the therapeutic pipeline, advancing the clinical study program and supporting IP and regulatory strategies. GlobeNewswire Inc

Nov 8, 2021

07:50AM EST Greater Cannabis Company, Inc. (GCANRx or the Company) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid therapeutics and consumer products today announced that it has begun the preclinical phase of assessing its novel neuropsychiatric cannabinoid therapy. GlobeNewswire Inc

Aug 30, 2021

10:51AM EDT Greater Cannabis Partners with Shaare Zedek Scientific on Innovative Neuropsychiatric Cannabinoid Therapy Benzinga

Aug 19, 2021

09:45AM EDT GCANRx Signs Licensing Agreement with Shaare Zedek Scientific for GlobeNewswire Inc

Mar 16, 2021

09:12AM EDT Greater Cannabis Company(OTCQB: GCAN), an innovator in the development and commercialization of cannabinoid delivery systems and cannabinoid products is proud to announce a collaboration with Israel-based cannabis lab, Phytor LTD, a leader in the research and development of plant-based therapeutics. GlobeNewswire Inc

Mar 9, 2021

08:00AM EST The Greater Cannabis Company Announces Relisting to OTCQB GlobeNewswire Inc

Mar 4, 2021

12:14PM EST Greater Cannabis Provides New and Improved Options for Cannabinoid Technology Delivery Systems Benzinga

Feb 23, 2021

09:53AM EST Greater Cannabis Co.(OTC: GCAN), an innovator in the development and commercialization of cannabinoid delivery systems and cannabinoid products is pleased to announce that Mr. Aitan Zacharin, GCAN Chief Executive Officer, will be presenting at the Benzinga Virtual Cannabis Investor Conference on February 26th at 10:35am EST on Track 1. GlobeNewswire Inc

Jan 20, 2021

08:57AM EST The Greater Cannabis Company (GCAN), an innovator in the development and commercialization of cannabinoid delivery systems and cannabinoid products today announced the retirement of $1.2million in convertible notes inclusive of principal and accrued interest, simplifying the Company's capital structure as it positions itself for growth. GlobeNewswire Inc

Nov 23, 2020

10:10AM EST Initial products to launch in Party City and online through e-tailer network for holiday season GlobeNewswire Inc

Aug 11, 2020

08:00AM EDT Collaboration will Focus on Development of Innovative CBD Health and Beauty Products GlobeNewswire Inc

Share